InspireMD to Announce First Quarter 2026 Financial Results

Rhea-AI Summary

InspireMD (Nasdaq: NSPR) will release its first quarter 2026 financial results on Monday, May 4, 2026 and will host a conference call and webcast at 4:30 p.m. Eastern Time.

Interested parties must register for phone participation via the online form; webcast registration sends dial-in details and a personal PIN. A live audio webcast and archived recording will be available on the company Investors page.

News Market Reaction – NSPR

-5.79%

2 alerts

-5.79% Session close to close

-11.5% Trough Tracked

$61.39M Market Cap

0.3x Rel. Volume

In the Apr 28 session, NSPR declined 5.79%, reflecting a notable negative market reaction. Argus tracked a trough of -11.5% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.8% in the session following this news. A negative reaction despite this being a r...

Analysis

The stock moved -5.8% in the session following this news. A negative reaction despite this being a routine earnings-date notice would fit a pattern where sentiment is shaped more by the company’s broader profile—recent losses, capital needs, and at-the-market capacity—than by logistics updates. With the stock trading well below its 200-day MA and near its 52-week low, investors might react cautiously ahead of Q1 2026 results, particularly if dilution or cash-burn concerns remain elevated.

Key Figures

Earnings release date: May 4, 2026 Conference call time: 4:30 p.m. Eastern Time Suggested early registration: 15 minutes

3 metrics

Earnings release date May 4, 2026 Scheduled first quarter 2026 financial results release

Conference call time 4:30 p.m. Eastern Time Time of Q1 2026 earnings call and webcast

Suggested early registration 15 minutes Participants encouraged to register more than 15 minutes before call

Previous Earnings date Reports

1 past event · Latest: Mar 09 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 09	Earnings date set	Neutral	+0.6%	Scheduled Q4 and full-year 2025 results with earnings call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history for earnings-date announcements; the single prior event saw a small positive move.

Recent Company History

This announcement sets the timing for InspireMD’s Q1 2026 results, similar to the prior earnings-date release on Mar 9, 2026 ahead of Q4 and full-year 2025 results. That earlier scheduling headline was followed by a modest 0.61% gain. Since then, the company has reported strong revenue growth but widening losses, added an at-the-market program, and highlighted pivotal trial data and U.S. commercialization progress.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MIAMI, April 27, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard^® Prime carotid stent system for the prevention of stroke, today announced that it will release its first quarter financial results on Monday, May 4, 2026. In conjunction with the release, InspireMD will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Parties interested in participating by phone should register using this online form. After registering for the webcast, dial-in details will be provided in an auto-generated e-mail containing a link to the conference phone number along with a personal pin. A live audio webcast and an archive of the recording will be available here and through the Investors page of InspireMD’s corporate website at https://investors.inspiremd.com. Interested participants are encouraged to register more than 15 minutes before the start of the call.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR.

We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contact:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com

FAQ

When will InspireMD (NSPR) release its first quarter 2026 financial results?

InspireMD will release first quarter 2026 financial results on Monday, May 4, 2026 at 4:30 p.m. Eastern Time. According to InspireMD, the company will discuss results on a conference call and webcast and provide a live audio stream and archive.

How can investors register for the InspireMD (NSPR) May 4, 2026 conference call?

Investors should register using the company's online registration form before the call to receive dial-in details and a personal PIN. According to InspireMD, registrants receive an auto-generated email with the conference phone number and PIN.

Where will the InspireMD (NSPR) live webcast and archive be available after the May 4, 2026 call?

The live audio webcast and archive will be available on the company's Investors page and webcast link. According to InspireMD, the recording will be posted on https://investors.inspiremd.com for later listening.

What time should participants join the InspireMD (NSPR) May 4, 2026 call and webcast?

The company scheduled the conference call and webcast for 4:30 p.m. Eastern Time on May 4, 2026; join at least 15 minutes early. According to InspireMD, participants are encouraged to register more than 15 minutes before the start.

What will InspireMD (NSPR) discuss during the May 4, 2026 earnings webcast?

InspireMD will discuss its first quarter 2026 financial results and recent corporate highlights during the webcast. According to InspireMD, the call is intended to review results and recent company developments for investors and analysts.